Assessing the relevance of in vitro studies in nanotoxicology by examining correlations between in vitro and in vivo data
about
Advances in inhalation dosimetry models and methods for occupational risk assessment and exposure limit derivationEstimating the effective density of engineered nanomaterials for in vitro dosimetryAt the Crossroads of Nanotoxicology in vitro: Past Achievements and Current ChallengesNew approach to investigate the cytotoxicity of nanomaterials using single cell mechanicsAn integrated approach for the in vitro dosimetry of engineered nanomaterialsTranscriptomic analysis reveals novel mechanistic insight into murine biological responses to multi-walled carbon nanotubes in lungs and cultured lung epithelial cellsEffects of silica and titanium oxide particles on a human neural stem cell line: morphology, mitochondrial activity, and gene expression of differentiation markersQuantifying and imaging engineered nanomaterials in vivo: challenges and techniques.Engineered nanomaterial risk. Lessons learnt from completed nanotoxicology studies: potential solutions to current and future challenges.Bridge over troubled waters: understanding the synthetic and biological identities of engineered nanomaterials.Complexity in the therapeutic delivery of RNAi medicines: an analytical challenge.Pulmonary toxicity of nanomaterials: a critical comparison of published in vitro assays and in vivo inhalation or instillation studies.Effect of particle agglomeration in nanotoxicology.A critical review of in vitro dosimetry for engineered nanomaterials.A Multilaboratory Toxicological Assessment of a Panel of 10 Engineered Nanomaterials to Human Health--ENPRA Project--The Highlights, Limitations, and Current and Future Challenges.Simple in vitro models can predict pulmonary toxicity of silver nanoparticles.Acute toxicity of silver and carbon nanoaerosols to normal and cystic fibrosis human bronchial epithelial cells.TiO2 nanoparticles induce DNA double strand breaks and cell cycle arrest in human alveolar cells.Alternative Testing Strategies for Nanomaterials: State of the Science and Considerations for Risk Analysis.Mechanisms allowing protein delivery in nasal mucosa using NPL nanoparticles.Effect of Particulate Matter Air Pollution on Cardiovascular Oxidative Stress Pathways.The roles of surface chemistry, dissolution rate, and delivered dose in the cytotoxicity of copper nanoparticles.Nanobarcoded superparamagnetic iron oxide nanoparticles for nanomedicine: Quantitative studies of cell-nanoparticle interactions by scanning image cytometry.Indium oxide (In2O3) nanoparticles induce progressive lung injury distinct from lung injuries by copper oxide (CuO) and nickel oxide (NiO) nanoparticles.Adoption of in vitro systems and zebrafish embryos as alternative models for reducing rodent use in assessments of immunological and oxidative stress responses to nanomaterials.In Vitro and In Vivo Short-Term Pulmonary Toxicity of Differently Sized Colloidal Amorphous SiO₂.Characterization of Nanoparticle Batch-To-Batch Variability.Combustion-derived particles inhibit in vitro human lung fibroblast-mediated matrix remodelingIterative Cellular Screening System for Nanoparticle Safety Testing
P2860
Q23912442-846AD9CB-2364-4FCF-91C4-AFC8B52251A6Q23913174-1EADCF2A-FF03-4DFE-B35E-85763CA2B9A3Q26796677-49CAF429-6021-4F44-BB2C-3465C932A70EQ28383691-6AFDEE3D-A70C-4466-9603-CC4F2FCF39F6Q28386114-7DF2C53C-9633-4986-9DCA-5FB2F9D3419EQ28391236-B4B78A5A-5B08-457D-A817-0E6C7E506D9EQ28392813-AA290E5E-64C1-401A-ACAB-0F520A0B877FQ38048694-A09BB01D-C1F5-43F9-8574-5A2B2C40928AQ38057778-46927547-44BB-40AE-9D07-149917E2DEC9Q38075542-FA82B4A1-FC5D-4F12-93EF-C8A7412A9AD1Q38221915-386C86E1-F7C1-4F06-A108-656181FE1145Q38285750-333D4446-B153-40C8-912E-DD89D7983BDDQ38331210-71DE4A41-758A-4A43-95FF-F32110155754Q38595356-005CA74C-CBA4-4816-AEE6-73E00B9C6CDDQ38794215-206E42B5-F4FE-482D-93A6-518CB9A3102CQ38799484-5975967C-514C-4410-9924-A3C49A6F12D6Q38870826-E7F00BDF-1E76-4365-A2B2-C4DDFDFC561CQ38927034-7D9DB001-EB30-474B-AB77-3DD59F788193Q39702398-3A65F22C-DA0E-445C-837A-78DEEBAD7617Q40713612-64801D30-BB20-43E6-B67D-016C0064C676Q46272229-69ACD718-FC47-4670-8E2D-447B9BCCF95AQ46399790-C7FBC7F6-71A3-43CD-BC0B-76D5AD3C628CQ46723706-64CD1C45-21B5-4B56-A0B1-71A4E02BC0D5Q46765442-5FF08185-23B3-4E24-8E7B-3ECAA07D53E3Q48119346-A0780AF4-DEF6-4197-BBA8-79CB22A7C564Q51147702-949D7819-0703-4217-BC9A-7A2E912F51F6Q55026013-DCD5B504-95FD-44AD-87B8-41A3F82166C7Q58111450-C79E2721-69ED-4AE5-BED1-1E129156B340Q59113954-59AD60E1-086C-4466-80AF-6FCEB1A5B998
P2860
Assessing the relevance of in vitro studies in nanotoxicology by examining correlations between in vitro and in vivo data
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Assessing the relevance of in ...... ween in vitro and in vivo data
@ast
Assessing the relevance of in ...... ween in vitro and in vivo data
@en
Assessing the relevance of in ...... ween in vitro and in vivo data
@nl
type
label
Assessing the relevance of in ...... ween in vitro and in vivo data
@ast
Assessing the relevance of in ...... ween in vitro and in vivo data
@en
Assessing the relevance of in ...... ween in vitro and in vivo data
@nl
prefLabel
Assessing the relevance of in ...... ween in vitro and in vivo data
@ast
Assessing the relevance of in ...... ween in vitro and in vivo data
@en
Assessing the relevance of in ...... ween in vitro and in vivo data
@nl
P2093
P2860
P1433
P1476
Assessing the relevance of in ...... ween in vitro and in vivo data
@en
P2093
Alison Elder
Günter Oberdörster
Jacob N Finkelstein
Jingkun Jiang
Manoranjan Sahu
Nancy Corson
Pamela Wade-Mercer
Pratim Biswas
Robert Gelein
Xianglu Han
P2860
P356
10.1016/J.TOX.2012.03.006
P407
P577
2012-07-16T00:00:00Z